Arthur Boni

DOI:https://doi.org/10.5912/jcb908


Abstract:

Startups are an important source of innovation for any industry, particularly for disruptive or transformative innovations enabled by technology. Therefore, it is no surprise that the startup community has been and continues to be an essential component at the “front end” of the evolving ecosystem for biopharma, MedTech and digital medicine. Challenges exist for the startups, the evolving community of accelerators, and their commercializing partners who form alliances with the startup community to achieve and accelerate transformative innovation.